Intermediate filaments enable pathogen docking to trigger type 3 effector translocation.

Russo, Brian C; Stamm, Luisa M; Raaben, Matthijs; Kim, Caleb M; Kahoud, Emily; Robinson, Lindsey R; Bose, Sayantan; Queiroz, Ana L; Herrera, Bobby Brooke; Baxt, Leigh A; Mor-Vaknin, Nirit; Fu, Yang; Molina, Gabriel; Markovitz, David M; Whelan, Sean P; Goldberg, Marcia B

Russo, Brian C; Stamm, Luisa M; Raaben, Matthijs; Kim, Caleb M; Kahoud, Emily; Robinson, Lindsey R; Bose, Sayantan; Queiroz, Ana L; Herrera, Bobby Brooke; Baxt, Leigh A; Mor-Vaknin, Nirit; Fu, Yang; Molina, Gabriel; Markovitz, David M; Whelan, Sean P; Goldberg, Marcia B.

Affiliation

Russo BC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Stamm LM; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Raaben M; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Kim CM; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Kahoud E; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Robinson LR; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Bose S; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Queiroz AL; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Herrera BB; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Baxt LA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Mor-Vaknin N; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Fu Y; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Molina G; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Markovitz DM; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
Whelan SP; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Goldberg MB; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Nat Microbiol ; 1: 16025, 2016 Mar 07.

Article de En | MEDLINE | ID: mdl-27572444

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Salmonella typhimurium / Shigella flexneri / Vimentine / Adhérence bactérienne / Yersinia pseudotuberculosis / Facteurs de virulence / Systèmes de sécrétion de type III Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Nat Microbiol Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google